P.08.7 CLINICAL IMPLICATIONS AND STABILITY OF DETERMINATION OF INFLIXIMAB TROUGH LEVELS (IFX-TL) AND ANTIBODIES TO INFLIXIMAB (ATI) IN INFLAMMATORY BOWEL DISEASE
Daperno, M, Fracchia, M, Guiotto, C, Germano, L, Ercole, E, Rigazio, C, Lavagna, A, Migliardi, M, Pellerito, R, Rocca, R
Published in Digestive and liver disease (01.03.2013)
Published in Digestive and liver disease (01.03.2013)
Get full text
Journal Article
P.03.13 COMPARISON OF THE PERFORMANCE OF TWO COMMERCIALLY AVAILABLE TESTS FOR DETERMINATION OF INFLIXIMAB TROUGH LEVELS (IFX-TL) AND ANTIBODIES TO INFLIXIMAB (ATI), PROMONITOR AND IMMUNDIAGNOSTIK, IN INFLAMMATORY BOWEL DISEASE
Daperno, M, Frigerio, F, Guiotto, C, Laura, G, Ercole, E, Lavagna, A, Rigazio, C, Aricò, S, Migliardi, M, Pellerito, R, Rocca, R
Published in Digestive and liver disease (01.03.2013)
Published in Digestive and liver disease (01.03.2013)
Get full text
Journal Article
T.03.3 FECAL SMALL NON-CODING RNAS AND MICROBIOME CHARACTERIZE PATIENTS WITH CELIAC DISEASE
Francavilla, A., Ferrero, G., Pardini, B., Tarallo, S., Zanatto, L., Caviglia, G.P., Sieri, S., Grioni, S., Francescato, G., Stalla, F., Guiotto, C., Crocellà, L., Astegiano, M., Bruno, M., Vineis, P., Ribaldone, D.G., Naccarati, A.
Published in Digestive and liver disease (01.05.2022)
Published in Digestive and liver disease (01.05.2022)
Get full text
Journal Article
P.07.1 SWITCHING FROM INFLIXIMAB ORIGINATOR TO A FIRST BIO SIMILAR IS SAFE AND EFFECTIVE. A SINGLE CENTER SERIES WITH THROUGH LEVELS AND ANTI-DRUG ANTIBODIES DETERMINATION
Daperno, M., Guiotto, C., Italia, A., Lavagna, A., Negri, A., Ercole, E., Cosimato, M., Rigazio, C., Rocca, R.
Published in Digestive and liver disease (15.03.2018)
Published in Digestive and liver disease (15.03.2018)
Get full text
Journal Article
P588 Switching from infliximab originator to a first biosimilar is safe and effective: A single-centre series with through levels and anti-drug antibodies determination
Daperno, M, Guiotto, C, Italia, A, Lavagna, A, Negri, A, Ercole, E, Cosimato, M, Rigazio, C, Rocca, R
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
P569 Clinical correlations of infliximab trough levels (IFX-TL) and antibodies to infliximab (ATI) in inflammatory bowel disease
Daperno, M., Lavagna, A., Fracchia, M., Guiotto, C., Germano, L., Rigazio, C., Ercole, E., Migliardi, M., Pellerito, R., Rocca, R.
Published in Journal of Crohn's and colitis (01.02.2013)
Published in Journal of Crohn's and colitis (01.02.2013)
Get full text
Journal Article
P508 Evaluation of the diagnostic performance of two commercially available tests for infliximab trough levels (IFX-TL) and antibodies to infliximab (ATI) titration in inflammatory bowel disease (IBD)
Daperno, M., Frigerio, F., Guiotto, C., Germano, L., Ercole, E., Aricò, S., Fracchia, M., Rigazio, C., Lavagna, A., Pellerito, R., Migliardi, M., Rocca, R.
Published in Journal of Crohn's and colitis (01.02.2013)
Published in Journal of Crohn's and colitis (01.02.2013)
Get full text
Journal Article